![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 10
Zeitschriftenartikel
Hadi, I.; Schummer, A.; Dreyling, M.; Eze, C.; Bodensohn, R.; Roengvoraphoj, O.; Belka, Claus 
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, M.
(2021):
Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin's lymphoma: a monocenter analysis.
In: Scientific reports, Bd. 11, 22586
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, M.
(2021):
Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin's lymphoma: a monocenter analysis.
In: Scientific reports, Bd. 11, 22586
[PDF, 1MB]
Hadi, I; Schummer, A.; Dreyling, M.; Eze, C.; Bodensohn, R.; Roengvoraphoj, O.; Belka, C. und Li, M.
(2021):
Effectiveness and tolerability of radiotherapy for patients with indolent non-Hodgkin's lymphoma: a monocenter analysis.
In: Scientific Reports, Bd. 11, Nr. 1, 22586
Unterrainer, M.; Eze, C.; Ilhan, H.; Marschner, S.; Roengvoraphoj, O.; Schmidt-Hegemann, N. S.; Walter, F.; Kunz, W. G.; Munck af Rosenschold, P.; Jeraj, R.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
ORCID: https://orcid.org/0000-0003-0953-7624; Grosu, A. L.; Niyazi, M.; Bartenstein, P. und Belka, C.
(2020):
Recent advances of PET imaging in clinical radiation oncology.
In: Radiation Oncology, Bd. 15, Nr. 1, 88
Roengvoraphoj, O.; Eze, C.; Fendler, W.; Dantes, M.; Belka, C. und Manapov, F.
(2017):
Prognostic value of pre-to post-treatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a patient cohort with inoperable locally-advanced NSCLC treated with definitive chemoradiotherapy.
In: Annals of Oncology, Bd. 28
Roengvoraphoj, O.; Eze, C.; Wijaya, C.; Fendler, W.; Belka, C. und Manapov, F.
(2017):
Prognostic value of pre- to posttreatment primary tumor metabolic volume reduction on 18F-FDG-PET/CT in a homogeneous patient cohort with inoperable locally-advanced non-small cell lung cancer treated with definitive chemoradiotherapy.
In: Strahlentherapie und Onkologie, Bd. 193:
S144-S144
Hadi, I; Roengvoraphoj, O.; Niyazi, M.; Röder, F.; Belka, C. und Nachbichler, S.
(2017):
Medulloblastoma in adults: A retrospective single institution analysis.
In: Strahlentherapie und Onkologie, Bd. 193:
S158-S158
Roengvoraphoj, O.; Eze, C.; Li, M. und Manapov, F.
(2017):
Symptomatic pneumonitis in the irradiated lung after nivolumab: case study.
In: Strahlentherapie und Onkologie, Bd. 193:
S143-S143
Roengvoraphoj, O.; Eze, C.; Li, M. und Manapov, F.
(2017):
Symptomatic pneumonitis in the irradiated lung after nivolumab: Three case studies.
In: Annals of Oncology, Bd. 28
Roengvoraphoj, O.; Wijaya, C.; Eze, C.; Fendler, W.; Gerum, S.; Belka, C. und Manapov, F.
(2016):
Impact of the primary tumor metabolic volume (PT-MV) changes in the course of multimodality treatment on overall survival in patients with locally-advanced non-small cell lung cancer.
In: Journal of thoracic Oncology, Bd. 11, Nr. 4:
S109-S109
Eze, C.; Roengvoraphoj, O.; Gerum, S.; Belka, C. und Manapov, F.
(2016):
Maximum treatment response and prophylactic cranial irradiation are important prognostic factors in limited disease small-cell lung cancer patients comprehensively staged with cranial magnetic resonance imaging.
In: Journal of thoracic Oncology, Bd. 11, Nr. 4:
S111-S111